Author

Stéphane Giraud

Centre Léon BérardORCID 0000-0002-7796-9827Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Angéline Gaucherot· 1 shared Camille Jouines· 1 shared Carine FromentiD· 1 shared Caroline IsaaciD· 1 shared Christophe VanbelleiD· 1 shared Fleur BourdelaisiD· 1 shared Flora Nguyen Van LongiD· 1 shared Frédéric CateziD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Angéline Gaucherot

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyBreast Cancer ResearchPeer-reviewedNov 13, 2025

Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer

Camille Jouines, Piero Lo Monaco, Angéline Gaucherot…·Frédéric Catez

This study identifies ribosome biogenesis as a therapeutic vulnerability in TNBC, showing that inhibiting rRNA maturation via Fibrillarin or RNA Pol I reduces tumor growth without significant cell death.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky